Cargando…
Risk management of biosimilars in oncology: each medicine is a work in progress
Drug licensing and drug safety monitoring for standard chemical entities have been established and are routinely used. These have resulted in a solid foundation of knowledge from which confident therapeutic decisions can be made. For many chemical entities, this advanced level of experience is also...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291842/ https://www.ncbi.nlm.nih.gov/pubmed/22274817 http://dx.doi.org/10.1007/s11523-011-0188-3 |